Compare GSL & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GSL | STAA |
|---|---|---|
| Founded | 2007 | 1982 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Ophthalmic Goods |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2008 | 1995 |
| Metric | GSL | STAA |
|---|---|---|
| Price | $44.48 | $23.52 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $44.00 | $22.81 |
| AVG Volume (30 Days) | 363.5K | ★ 852.7K |
| Earning Date | 05-18-2026 | 05-12-2026 |
| Dividend Yield | ★ 6.34% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | N/A | ★ $239,442,000.00 |
| Revenue This Year | N/A | $30.82 |
| Revenue Next Year | N/A | $8.41 |
| P/E Ratio | ★ $3.49 | $86.88 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $27.28 | $15.59 |
| 52 Week High | $45.45 | $35.87 |
| Indicator | GSL | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 59.19 | 45.76 |
| Support Level | $37.00 | $23.27 |
| Resistance Level | $45.07 | $26.21 |
| Average True Range (ATR) | 0.98 | 1.14 |
| MACD | 0.05 | -0.03 |
| Stochastic Oscillator | 75.63 | 36.87 |
Global Ship Lease Inc is a containership owner, leasing ships to container shipping companies under industry-standard, fixed-rate time charters. Its fleet comprises mid-size Post-Panamax, Cypress, and smaller containerships, which tend to serve the faster-growing non-Mainlane and intra-regional trades, collectively representing the majority of the containerized trade volume globally. The company generates revenue from chartering its vessels to liner companies.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.